arrow
Back
A

Alexander I. Spira

Virginia Cancer Specialists

67H-index
943Paper Count
2.8WCitation Count
Published Papers 175
Publication Date
Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC
err2025-11-29
err0
PREAI
errTimothy F. Burns; Natraj Reddy Ammakkanavar; Antoine Hollebecque; Dae Ho Lee; Takafumi Koyama; Philippe A. Cassier; Antoine Italiano; Ji-Youn Han; Nimit Singhal; Shinji Takeuchi; Rebecca S. Heist; Dustin Deming; Alexander Spira; Quincy Chu; Adrian Sacher; Yutaka Fujiwara; Michael J. Chisamore; Arthur Xintian You; Samuel C. McNeely; Aaron Fink
errShare
errSave
Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLC
err2025-11-17
err0
PREAI
errAlexander I. Spira; David Berz; Robert M. Jotte; Krishna Kishore Pachipala; Mark S. Berger
errShare
errSave
Trial in Progress (TiP): Interim analysis of a Phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with Vitamin K in combination with Standard of Care (SOC) RT and TMZ in Glioblastoma Multiforme (GBM) patients without prior therapy
err2025-11-01
err0
errOAAI
errNagpal, Seema; Stockdale, Brian; Cohen, Adam; Patil, Chirag; Vaillant, Brian; Elmore, Kevin; Brenner, Andrew; Juthani, Rupa; Reardon, David; Kendle, Ryan; Spira, Alexander; Wykretowicz, Jedrzej; Zhukova-Harrill, Valentina; Nie, Bing; Narain, Niven; Modur, Vijay
errShare
errSave
errShare
errSave
Less frequent intravenous dosing of nemvaleukin alfa in patients with advanced solid tumors: the phase 1/2 ARTISTRY-3 trial
err2025-10-01
err0
errOAAI
errPiha-Paul, Sarina A.; Call, Justin A.; Spira, Alexander, I; Bartolome, Jorge; De Miguel, Maria; Chen, Xiwei; Donatelli, Sarah S.; Lakhani, Nehal J.
errShare
errSave
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial
err2025-09-09
err0
errOAAI
errByoung Chul Cho; Weimin Li; Alexander I. Spira; Maxwell Sauder; Jill Feldman; Farastuk Bozorgmehr; Milena Mak; Janellen Smith; Pei Jye Voon; Baogang Liu; Panwen Tian; Jiunn-Liang Tan; Cheng-Ta Yang; Jin-Yuan Shih; Nuri Karadurmus; Juan Esteban Cundom; Glaucio Bertollo; Irfan Cicin; Jorge Nieva; Ana Laura Ortega-Granados; Pascale Tomasini; Danny Nguyen; Enriqueta Felip; Julia Schuchard; Sean P. Murphy; Bailey G. Anderson; Tonatiuh Romero; Yichuan Xia; Shubin Sheng; Joshua M. Bauml; Parthiv J. Mahadevia; Julian Kam; Mehregan Nematian-Samani; Jairo Simoes; Mark Wildgust; Nicolas Girard
errShare
errSave
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
err2025-09-01
err9
PREAI
errYang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
errShare
errSave
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan
err2025-08-05
err0
errOAAI
errHope Rugo; Aditya Bardia; Debora S. Bruno; Vinicius Ernani; Erika Hamilton; Rebecca Heist; Komal Jhaveri; Benjamin Levy; Aaron Lisberg; Joyce O’Shaughnessy; Jacob Sands; Alexander Spira; Sara Tolaney; Nathaniel S. Treister; Cecile Matthews; Melissa Johnson
errShare
errSave
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory EGFR-mutated Non-small Cell Lung Cancer: Patient Satisfaction and Resource Utilization Results from the PALOMA-3 Study
err2025-07-10
err0
errOAAI
errMariam Alexander; Ying Cheng; Se-Hoon Lee; Antonio Passaro; Alexander I. Spira; Byoung Chul Cho; Sun Min Lim; Yuichiro Ohe; Adnan Nagrial; Jiunn Liang Tan; Vanina Wainsztein; Elisa Ramos; Maria del Rosario Garcia Campelo; Hiroaki Akamatsu; Danny Nguyen; Alexis B. Cortot; Alona Zer; Dilek Erdem; Rachel E. Sanborn; Till-Oliver Emde; Natasha B. Leighl
errShare
errSave
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study
err2025-05-16
err0
PREAI
errMatthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
errShare
errSave
Real-world comparative effectiveness of sotorasib versus docetaxel in second line and beyond among patients with advanced non-small cell lung cancer (NSCLC)( vol 197 , 107960 , 2024)
err2025-02-01
err0
errOAAI
errJohnson, Melissa; Younan, Diana; Kent, Shia T.; Frias, Marco Mesa; Brookhart, M. Alan; Balasubramanian, Akhila; Spira, Alexander
errShare
errSave
Preventing Infusion-Related Reactions With Intravenous Amivantamab—Results From SKIPPirr, a Phase 2 Study: A Brief Report
err2025-01-24
err0
errOAAI
errAlexander I. Spira; Luis Paz-Ares; Ji-Youn Han; Jin-Yuan Shih; Céline Mascaux; Upal Basu Roy; Jon Zugazagoitia; Yu Jung Kim; Chao-Hua Chiu; Sang-We Kim; Ernest Nadal; Ignacio Gil-Bazo; Sean P. Murphy; Bailey G. Anderson; Yichuan Xia; George Wang; Joshua M. Bauml; Marc Chioda; Jairo Simoes; Parthiv J. Mahadevia; Gilberto Lopes
errShare
errSave
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
err2024-10-24
err25
PREAI
errCho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi
errShare
errSave
First Clinical Results from A Phase 1 Trial of PRT3789, a First-in-Class Intravenous SMARCA2 Degrader, in Patients with Advanced Solid Tumors with a SMARCA4 Mutation
err2024-10-01
err0
PREAI
errYap, T. A.; Dowlati, A.; Dagogo-Jack, I.; Vibert, J.; Spira, A. I.; Garcia, V. Moreno; Punekar, S. R.; Calvo, E.; Sonpavde, G. P.; Awad, M.; Riess, J. W.; Hernandez-Guerrero, T.; Herzberg, B.; Italiano, A.; Swalduz, A.; LoRusso, P.; Smit, E. F.; Garon, E. B.; Novotny, W.; Guo, R.
errShare
errSave
Preliminary results from SEACRAFT-1: An open-label study of naporafenib with trametinib in patients with locally advanced unresectable or metastatic solid tumor malignancies with RAS Q61X mutations
err2024-10-01
err0
PREAI
errFontana, E.; Spira, A. I.; McKean, M.; Lee, J.; Chau, N.; Winquist, E.; Kim, I.; Hong, S. H.; Van Tine, B. A.; Fawole, A.; Shoemaker, R.; Cui, Y.; Sutton, R.; Antal, J. M.; Morris, S. R.; Hong, D. S.
errShare
errSave
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
err2024-09-01
err5
errOAAI
errFelip, E.; Cho, B. C.; Gutierrez, V; Alip, A.; Besse, B.; Lu, S.; Spira, A. I.; Girard, N.; Califano, R.; Gadgeel, S. M.; Yang, J. C-H.; Yamamoto, S.; Azuma, K.; Kim, Y. J.; Lee, K. -H.; Danchaivijitr, P.; Ferreira, C. G.; Cheng, Y.; Sendur, M. A. N.; Chang, G. -C.; Wang, C. -C.; Prabhash, K.; Shinno, Y.; Stroyakovskiy, D.; Paz-Ares, L.; Rodriguez-Cid, J. R.; Martin, C.; Campelo, M. R. G.; Hayashi, H.; Nguyen, D.; Tomasini, P.; Gottfried, M.; Dooms, C.; Passaro, A.; Schuler, M.; Gelatti, A. C. Z.; Owen, S.; Perdrizet, K.; Ou, S. -H. I.; Curtin, J. C.; Zhang, J.; Gormley, M.; Sun, T.; Panchal, A.; Ennis, M.; Fennema, E.; Bauml, J. M.; Daksh, M.; Sethi, S.; Lee, S. -H.
errShare
errSave
Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors
err2024-09-01
err0
PREAI
errMarron, T.; Segar, J.; Berlin, J. D.; Boccia, R.; Spira, A. I.; Powderly, J.; Chen, C.; Wainberg, Z. A.; Schanzer, J. M.; Glenn, J.; Klumpp, K.; Csiki, I.; Misleh, J. G.
errShare
errSave
Efficacy and safety of sacituzumab govitecan (SG) in patients with advanced/metastatic endometrial cancer (EC): Updated results from TROPiCS-03
err2024-09-01
err0
PREAI
errCorr, B. R.; Dumbrava, E. E.; Willmott, A. I. Spira L.; Butrynski, J. E.; Tse, K. Y.; Patel, J.; Mekan, S.; Mocci, S.; Wu, T.; Santin, A. D.
errShare
errSave